Report Descriptions:

The Global Opioid Use Disorder Market was estimated at USD 5.323 million in 2025 and is projected to reach USD 12.28 million by 2034, reflecting a robust CAGR of 12.16% over the forecast period from 2025 to 2034. The Opioid Use Disorder market report offers a comprehensive and nuanced view of the industry, moving beyond conventional analysis. It provides a thorough examination of the markets dynamics, encompassing a detailed exploration of the factors propelling growth, such as evolving economic conditions, advancements in technology, shifts in regulatory policies, and changes in consumer behavior. Furthermore, the report discusses the projected Compound Annual Growth Rate (CAGR), providing stakeholders with a clear understanding of the market's expected growth trajectory and offering data-driven insights into future market dynamics.

The Opioid Use Disorder market under analysis is characterized by dynamic growth and evolving trends that are reshaping the competitive landscape. With 2023 serving as the base year for this Opioid Use Disorder market study, recent data highlights a significant expansion driven by technological advancements, rising consumer demand, and a growing focus on innovation. Companies are refining their go-to-market (GTM) strategies to effectively capture these emerging opportunities and respond to the rapidly changing market dynamics.

Key trends influencing the Opioid Use Disorder market include the rapid adoption of digital technologies, the integration of sustainable practices, and the increasing importance of customer experience. These trends are not only driving growth but also creating new challenges for industry participants, who must adapt their GTM strategies to navigate regulatory changes, supply chain disruptions, and fluctuating economic conditions. Despite these challenges, the Opioid Use Disorder market is poised for sustained growth, with emerging markets playing a critical role in the expansion of the industry.

Looking ahead, the Opioid Use Disorder market is forecasted to continue its upward momentum through 2034, supported by ongoing investments in research and development, strategic partnerships, and mergers and acquisitions. Companies that can effectively tailor their GTM strategies to the evolving market landscape, innovate, and meet shifting consumer demands are likely to achieve sustained success. Opioid Use Disorder market report provides a comprehensive analysis of the current market environment and offers valuable insights into the key drivers, challenges, and opportunities that will shape the industry's future over the next decade.This report offers a comprehensive analysis of market dynamics across various segments, regions, and countries, incorporating both qualitative and quantitative data. It covers the period from 2017 to 2034, providing a detailed examination of historical performance, current market conditions, and future projections.

Historical Analysis (2017-2023): The report presents a thorough review of market trends, performance metrics, and growth trajectories for the years 2017 through 2023. This historical perspective is crucial for understanding past market behavior and identifying patterns that influence current and future market dynamics.

Forecast and Projections (2025-2034): Building on historical data, the report provides forward-looking insights, including market forecasts and growth projections from 2023 to 2034. It details anticipated market trends, emerging opportunities, and potential challenges across different segments, regions, and countries.

Compound Annual Growth Rate (CAGR): The report includes a precise calculation of the compound annual growth rate (CAGR) for the forecast period of 2025 to 2034. This metric will be instrumental in assessing the expected growth trajectory and the overall market potential during the forecast period.

The Opioid Use Disorder (OUD) Market is experiencing sustained growth due to the rising prevalence of opioid addiction and increasing public health initiatives globally. Governments, healthcare providers, and pharmaceutical companies are prioritizing the development of medication-assisted therapies (MATs), such as buprenorphine and methadone, alongside behavioral therapy. The expanding burden of addiction, especially in North America and parts of Europe, is driving a surge in demand for both pharmacological and non-pharmacological treatment options.

From an insights standpoint, combination therapies and long-acting injectables are gaining traction for improving patient compliance and reducing relapse rates. There is also growing investment in digital therapeutics and tele-rehabilitation programs aimed at enhancing remote patient engagement. Moreover, stigma reduction and greater awareness campaigns are influencing higher treatment-seeking behavior, particularly among younger populations.

Country-level analysis reveals that the United States dominates the OUD market, largely due to its severe opioid epidemic and strong policy response, including funding via the Substance Abuse and Mental Health Services Administration (SAMHSA). Canada and the UK are also witnessing a rise in treatment infrastructure, supported by national health systems. On the other hand, low- and middle-income countries are slowly recognizing the burden of opioid misuse, though stigma and limited healthcare budgets pose challenges to treatment scalability.

Regional trends show North America leading in treatment adoption due to robust reimbursement policies and high public awareness. Europe is investing in integrated care models and harm reduction strategies like safe injection sites. Asia-Pacific is in early stages of market development, with countries such as Australia and Japan expanding mental health resources. Latin America and the Middle East & Africa are showing slow but steady progress, driven by NGO support and international funding to combat rising substance abuse rates.

R&D Investments: Companies are investing in next-generation MATs with fewer side effects and better efficacy to improve long-term recovery outcomes.

Public-Private Collaborations: Strategic alliances between government bodies and biotech firms are fostering rapid drug development and distribution.

Digital Health Integration: Telemedicine platforms and mobile apps are being introduced to support virtual therapy and medication tracking.

Awareness & Access: Non-profit organizations and government-funded programs are intensifying efforts to de-stigmatize OUD and widen access to care, especially in rural areas.

Study Period for the Opioid Use Disorder Market:

Opioid Use Disorder Market

Report Highlights:

Our team of experienced researchers has meticulously gathered and analyzed data to deliver a thorough examination of market dynamics, competitive landscape, and emerging technologies. With a focus on delivering actionable intelligence, this report aims to empower decision-makers with the information needed to make informed choices and stay ahead of the competition. Whether you are a seasoned industry player or a new entrant, our market research report serves as a strategic tool to navigate the complexities of the market, aiding in successful business planning and growth strategies.

Key Chapters of our Opioid Use Disorder Market Report includes:

Market Dynamics, Variables, and Industry Analysis:

This chapter of our Opioid Use Disorder market report provides an in-depth examination of the factors shaping the industry landscape. This section typically encompasses several key elements to offer a comprehensive understanding of the industry landscape such as market drivers & restraints analysis, market opportunities & trend analysis, market size & growth analysis, competitive analysis, SWOT analysis, business environment tools such as Porter's five forces & PESTEL analysis, Ansoff Matrix analysis, penetration & growth prospect analysis, regulatory framework & reimbursement scenario analysis, impact of macro & micro economic factors analysis such as Covid-19 impact, GDP growth, market inflation, U.S.- China trade war, Russia-Ukraine war impact, and supply chain analysis.

Segment Analysis & Forecast to 2034:

The segment analysis chapter of Opioid Use Disorder market report is a critical section that delves into a detailed examination of the market's various segments. Segmentation involves dividing the market into distinct categories based on certain criteria to better understand and address the diverse needs of consumers. This chapter typically follows the introduction and provides a more granular view of the market, offering valuable insights for businesses and stakeholders. The components of the chapter lude segment definitions to understand the inclusions and exclusions of the study, assumptions, market size estimates and growth trend analysis of each segment, qualitative analysis of the segment, technological advancements, market penetration rate, market adoption rate, market share examination by each segment, segment growth drivers and restraint barriers, consumer behaviour and challenge analysis.

Regional Market Analysis & Forecast to 2034:

The chapter in Opioid Use Disorder market research report is a pivotal section that examines and predicts the market dynamics and trends specific to different geographical regions. This chapter is crucial for businesses and stakeholders seeking a comprehensive understanding of how the market behaves across various locations, enabling them to tailor strategies and make informed decisions based on regional variations. The regional analysis chapter of our Opioid Use Disorder market report is classified into regions & country-level. The chapter consists of North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).

Opioid Use Disorder Market

Competitive Analysis & Company Profiles:

This section of a Opioid Use Disorder market report is a crucial segment that provides a comprehensive overview of the competitive landscape within the market. This section is vital for businesses, investors, and stakeholders seeking insights into key players, their market positioning, strengths, weaknesses, strategies, and potential impacts on the overall market dynamics. The chapter includes research methodology used to analyse the market competition, list of key players operating in the market, detailed company profile section which includes company overview, business verticals, financial performance, product/services benchmarking, geographical presence, and strategic initiatives.

• Indivior PLC Developer of Suboxone and Sublocade for OUD treatment.
• Alkermes plc Manufacturer of Vivitrol, a long-acting opioid antagonist.
• Pfizer Inc.
• Teva Pharmaceuticals
• BioDelivery Sciences International (acquired by Collegium)
• Camurus AB
• Rhodes Pharmaceuticals
• Hikma Pharmaceuticals
• Amneal Pharmaceuticals
• Sun Pharmaceutical Industries
• Dr. Reddys Laboratories
• Emergent BioSolutions
• Mylan N.V

Opioid Use Disorder Market

Report Scope:

Based on Drug Type, the Opioid Use Disorder market is segmented into:

• Buprenorphine
• Methadone
• Naltrexone
• Clonidine
• Others (Nalmefene, Lofexidine)

Based on Route of Administration, the Opioid Use Disorder market is segmented into:

• Oral
• Injectable
• Transdermal
• Implantable

Based on Distribution Channel, the Opioid Use Disorder market is segmented into:

• Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Rehabilitation Centers

Based on Treatment Setting, the Opioid Use Disorder market is segmented into:

• Inpatient Treatment
• Outpatient Treatment
• Homecare

Key Reasons to Acquire the Opioid Use Disorder Market Research Report:

• This report offers a comprehensive analysis of the Opioid Use Disorder market from 2017 to 2034, including market segments, current trends, estimations, and dynamics
• It also provides information on key drivers, restraints, and opportunities
• Porter's five forces analysis is used to assess the potency of buyers and suppliers, helping stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network
• The report includes an in-depth analysis of the Opioid Use Disorder market segmentation to identify prevailing market opportunities
• Major countries in each region are mapped according to their revenue contribution to the global market
• Market player positioning is also analyzed to facilitate benchmarking and provide a clear understanding of the present position of the market players
• The report includes an analysis of the regional and global Opioid Use Disorder market trends, key players, market segments, application areas, and market growth strategies

Opioid Use Disorder Market

Available Customizations:

With the given market data, Quintile Reports offers customizations according to the company's specific needs. The following customization options are available for the report:

• You may ask for a global, regional, or country-specific report.
• You may ask if there are any particular types, applications, or products on which you would like to focus.
• You may ask for specific competitors/players to be profiled.

Opioid Use Disorder Market Report

Statistics for the 2024 Opioid Use Disorder market share, size, and revenue growth rate were created by Quintile Report™. Opioid Use Disorder analysis includes a market forecast outlook for 2034 and a historical overview. Get a free PDF sample of this market analysis, please get in touch with our principal analyst at sales@quintilereports.com